Healthline: Controversial studies find COVID-19 may be far more widespread than previously known
UC expert says lack of testing could be a factor
Healthline interviewed Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases for a news story on two studies in California finding that COVID-19 may be much more widespread than previously thought.
Dr. Carl Fichtenbaum of the UC Division of Infectious Diseases. Photo/Colleen Kelley/UC Creative + Brand
Fichtenbaum said one of the reasons for the discrepancy was a lack of testing.
“Because testing for the virus is not widely available due to lack of supplies, reagents, and machines, it’s not surprising that a sero-epidemiologic survey would find more individuals with infection,” Fichtenbaum said.
Read the entire article here.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.
What is squalane, and how does it work to moisturize skin?
October 27, 2025
The University of Cincinnati's Kelly Dobos was featured in a Women's Health article discussing squalane, an ingredient being increasingly used in moisturizing skincare products.